Back
Charter Communications Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
64
CHTR
Charter Communications
Last Price:
394.56
Seasonality Move:
5.14%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
46.99
Seasonality Move:
-15.89%
Buy
64
Charter Communications (CHTR)
is a Buy
Is Charter Communications a Buy, Sell or Hold?
- The current Charter Communications [CHTR] share price is $396.97. The Score for CHTR is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CHTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHTR Stock Price Chart
What is Charter Communications's stock price today?
-
The Charter Communications share price today is $396.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
CHTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.98 | Buy |
| Relative Strength Index (14 RSI): | 63.06 | Buy |
| Chaikin Money Flow: | 507298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (352.65 - 402.73) | Buy |
| Bollinger Bands (100): | (320.74 - 374.38) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 58.93 | Buy |
| Chaikin Money Flow: | 115403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.12 - 49.42) | Buy |
| Bollinger Bands (100): | (-5.11 - 34.85) | Buy |
CHTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 388.45 | Buy |
| 20-day SMA: | 389.51 | Buy |
| 50-day SMA: | 352.34 | Buy |
| 200-day SMA: | 313.84 | Buy |
| 8-day EMA: | 390.04 | Buy |
| 20-day EMA: | 381.79 | Buy |
| 50-day EMA: | 363.02 | Buy |
| 200-day EMA: | 339.49 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Buy |
| 20-day SMA: | 42.3 | Buy |
| 50-day SMA: | 28.61 | Buy |
| 200-day SMA: | 8.06 | Buy |
| 8-day EMA: | 39.27 | Buy |
| 20-day EMA: | 39.13 | Buy |
| 50-day EMA: | 31.07 | Buy |
| 200-day EMA: | 12.97 | Buy |
Charter Communications Earnings Growth & CHTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.94 per share, and an increase next year of $2.29 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Charter Communications Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||